DATAR CANCER GENETICS

In News

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA - PR Newswire

PR Newswire - May 14, 2026

Datar Cancer Genetics receives landmark US FDA clearance for CellDx-Tissue assay - BioSpectrum India

BioSpectrum India - May 16, 2026

Vineet Datta: Datar Cancer Genetics Europe Showcases Multi-Omic Profiling Insights at ESMO 2025 - Oncodaily

Oncodaily - Oct 30, 2025

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA - bastillepost.com

bastillepost.com - May 14, 2026

Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protoco - Devdiscourse

Devdiscourse - May 13, 2026

Datar Cancer Genetics Unveils Advanced Blood Test for MRD - Clinical Lab Products

Clinical Lab Products - Jan 30, 2025

Datar Cancer Genetics launches blood test for cancer monitoring - Medical Device Network

Medical Device Network - Jan 22, 2025

Datar Cancer Genetics Unveils Next Generation Multi-Analyte, AI-Powered Decision Support Platform for Personalized Treatment of Difficult-to-Treat Cancers. - PR Newswire

PR Newswire - Feb 03, 2025

Datar Announces $250M Contract for Cancer Detection Liquid Biopsies - Clinical Lab Products

Clinical Lab Products - May 10, 2022

FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics - PR Newswire

PR Newswire - Nov 19, 2021

Datar Cancer Genetics Unveils AI-Driven Video-Based Chemotherapy Testing - Clinical Lab Products

Clinical Lab Products - Jan 28, 2025

HC seeks panel report on plea seeking human trials for cancer vaccine - The Indian Express

The Indian Express - Dec 01, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment